No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
MeSH terms
-
ErbB Receptors* / genetics
-
Erlotinib Hydrochloride / therapeutic use
-
Humans
-
Lung Neoplasms* / drug therapy
-
Lung Neoplasms* / genetics
-
Lung Neoplasms* / pathology
-
Mutation
-
Portugal / epidemiology
Substances
-
Erlotinib Hydrochloride
-
EGFR protein, human
-
ErbB Receptors